RxDoctor Payments Data

Robert Ochs, MD

Procedural Dermatology · San Antonio, TXNPI 1043288277

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.7% of the total across 354 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations.

$11,465in general payments, 2019–2025

Across 354 payments — averaging $32.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Lilly USA, LLC$995
  • UCB, Inc.$811
  • Johnson & Johnson$811
  • Galderma Laboratories, L.p.$773
  • Sanofi$645
  • plus $5K from 22 others

What the payments were for

  • Travel & lodging$100%
  • Food & beverage$11,428100%
  • Education$270%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,465 in reported general payments places this provider in the 75th percentile of 25 procedural dermatology providers in Texas.

See all procedural dermatology providers in Texas

Medicare billing

Part B allowed, 2024
$116,826
Medicare patients
523
Services billed
2,620

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab34$296,346
Taltz AutoinjectorIxekizumab13$82,537
Clobetasol Propionate90$3,741
Doxycycline Hyclate76$2,140
Fluorouracil20$1,478
Ketoconazole71$1,353
Tetracycline Hcl14$1,246
Fluocinonide25$925
ValacyclovirValacyclovir Hcl26$784
Metronidazole14$692
Clindamycin Phosphate17$607
Tretinoin12$604
Triamcinolone Acetonide48$266
Ciclopirox13$237
Halobetasol Propionate14$218

Paid to pharmacies, not to this prescriber.

Other procedural dermatology in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →